RNA-mediated neurodegeneration in repeat expansion disorders. - Wikidata - awgldk - TriplyDB

RNA-mediated neurodegeneration in repeat expansion disorders.

RNA-mediated neurodegeneration in repeat expansion disorders.

http://www.wikidata.org/entity/Q37725827

about

The role of additional radiotherapy for primary central nervous system lymphoma Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)The role of additional radiotherapy for primary central nervous system lymphoma (PCNSL)Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders Structural studies of CNG repeats Mechanisms of RNA-induced toxicity in CAG repeat disorders RNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndrome Atomic resolution structure of CAG RNA repeats: structural insights and implications for the trinucleotide repeat expansion diseases Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans RNA phase transitions in repeat expansion disorders.Spinocerebellar ataxia type 36 in the Han Chinese Identification of genes in toxicity pathways of trinucleotide-repeat RNA in C. elegans.Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.Stabilization of RNA hairpins using non-nucleotide linkers and circularization.Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation.Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.5'CAG and 5'CTG Repeats Create Differential Impediment to the Progression of a Minimal Reconstituted T4 Replisome Depending on the Concentration of dNTPs.Polyglutamine repeats are associated to specific sequence biases that are conserved among eukaryotes.Milestones in ataxia Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis.Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS)Ubiquitous expression of CUG or CAG trinucleotide repeat RNA causes common morphological defects in a Drosophila model of RNA-mediated pathology The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.Fragile X mental retardation protein expression in Alzheimer's disease MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS The neurogenetics of atypical parkinsonian disorders Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.A network of RNA and protein interactions in Fronto Temporal Dementia.Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis Triadopathies: an emerging class of skeletal muscle diseases.

P2860

Q24193995-C10926A6-031C-4C40-ACCD-E3C08DC7FEFB Q24202784-74431BE1-FE17-4936-BF66-B4388CF472EB Q24236186-FD2B399B-92FB-431F-BA32-BB6445D87C25 Q24236726-7B026059-8FF6-42EA-8007-157A1FE6B6D9 Q24562489-51F4C4E7-50B5-4B82-89AF-958774DC4B7D Q24622048-A7A587E1-66A2-4667-8C4C-5BF0E5746B14 Q24633692-69BEFCE8-EAC5-4393-9169-CA2EF78311BF Q26764958-ABD4BE6D-AD56-47ED-9A5D-DFD301630A9A Q26828357-D3940913-E674-4AC7-9EF7-64FFD8F96459 Q26851232-901AD6E8-08D1-4E1E-8BE1-4276B8B68053 Q26860030-A8A51582-B395-4892-A338-CD52436ED2F5 Q26992035-D408761D-9A2E-416C-A774-41ECC011099D Q27664034-1560E1BE-FB6D-4028-A2E9-143E5150815A Q28079951-1C29AD09-B125-4A70-8651-696278F6AC30 Q28481587-2CE5306C-0FAF-4429-87CE-874E24D5BC5F Q30224330-0A4A17EA-C3F7-44AD-A508-15F655448E9C Q30385097-8AF95EDA-773D-4968-B356-D17EE0CCCB02 Q30586121-89350DA9-944D-4641-B39C-27F8A38C6312 Q33698593-D082E490-CFA6-4FCB-998A-337F54BEEAA0 Q33741196-6F278E61-2DE3-4581-872F-7AB8CD1BD862 Q33878156-DA7776C8-3D02-4A2C-B903-E4795C8D0F55 Q34019134-C643E538-F000-420D-9474-B0DB4295367A Q34061575-07FF53D3-6AA0-4701-8DF1-F069093A3A0B Q34078022-52EC803C-725C-4B96-800D-37DEABF74F04 Q34152667-CEBFF105-0A53-4FC8-B7B4-9F6B8A24BF51 Q34188468-D05F293C-E5DB-47E0-8DFF-91843B39677E Q34274478-27BB8E6F-0986-4A7E-A864-FB980DDF5C63 Q34304833-DC4FE2B0-BCB3-4A92-9E7A-DC8FFA3858DA Q34310291-C39572ED-1983-417C-A85B-A59E1AE87991 Q34313848-A73F7EB9-8829-490B-A0AC-AF97BEC4915F Q34521866-CF7741C3-EF62-411B-AFEB-57640EA85915 Q34640550-47F449EF-2421-409B-BCB9-9F594CAE6FC7 Q34659435-CC42B8C9-669B-4B8A-B040-804507E6CC14 Q34955465-03EF24DA-7275-4FBE-8B11-82676B42DE97 Q35008908-94DE6B98-052C-4C4F-B6EF-434C83F107EF Q35027822-6347CD7E-9A36-4AE8-9831-7DB02B781987 Q35103825-B5968DA9-343F-46FE-975C-0F9B2616EF67 Q35194634-1F6A698D-6CCC-4AE9-BEA3-40415756A516 Q35224241-00A75414-6059-4FDF-A7D3-66B64447E916 Q35340211-350A7E85-5F1A-47E9-838A-A775AF582B61

P2860

RNA-mediated neurodegeneration in repeat expansion disorders.

http://www.wikidata.org/entity/Q37725827

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

RNA-mediated neurodegeneration in repeat expansion disorders.

@en

RNA-mediated neurodegeneration in repeat expansion disorders.

@nl

type

label

RNA-mediated neurodegeneration in repeat expansion disorders.

@en

RNA-mediated neurodegeneration in repeat expansion disorders.

@nl

prefLabel

RNA-mediated neurodegeneration in repeat expansion disorders.

@en

RNA-mediated neurodegeneration in repeat expansion disorders.

@nl

P1433

Q37725827-FA886109-FDA7-465F-AB32-5E6B46D20668

P1476

Q37725827-03A97099-9363-4025-BD6F-0D7380480ACE

P2093

Q37725827-9D67F43E-B4C7-417E-9B0E-CE8CA70C63EE

Q37725827-BCEF8C4E-880E-4815-91A8-C13DB82A0C30

P2860

Q37725827-0565F188-4508-4873-9D65-65A7BBB4725A

Q37725827-05824569-F861-4984-B71E-0543F7DE9AD7

Q37725827-05AD58B0-4D5A-45C1-84D3-AF4FAC294BD6

Q37725827-0658B967-9C91-49AE-885C-0952C0A5007A

Q37725827-066D61F1-609C-435F-9343-035E732C1FF5

Q37725827-068875B6-96E6-4A23-ACE7-E2A5B7E4C4E9

Q37725827-0C96860C-4A8C-4CF5-B6D8-371F41ABFAF5

Q37725827-16E90A4E-826C-4E7B-AEA4-71E022202218

Q37725827-17315B57-9968-4CEA-9FB9-1CE34880CF63

Q37725827-21237001-2ABB-43D8-B7DB-336F40389F0A

P304

Q37725827-36DA9283-5958-4078-959E-0A3B10423ED2

P31

Q37725827-B4864EEF-8634-4B3C-B1FE-212610A6A7CF

P356

Q37725827-A8160FEA-E5E6-488A-AC3A-DA193FB9DD2D

P433

Q37725827-3B98A783-15D6-432B-AA48-8BC25ECAD723

P478

Q37725827-A652A253-A883-4D4B-AB21-4862A4CE10CD

P577

Q37725827-C3F062A1-1AB0-4F70-A06C-F15C1D9E331E

P698

Q37725827-FF8FD4C1-A7F4-409E-AD46-66539502E287

Q37725827-b1da8131-2496-4eaf-8830-8af3a95c8255

P932

Q37725827-2AFBC3E3-0C38-48F9-BDD1-2DE93C32F89C

P356

ARCHNEUROL.2010.3

P1433

Annals of Neurology

P1476

RNA-mediated neurodegeneration in repeat expansion disorders.

@en

P2093

Henry L Paulson

http://www.w3.org/2001/XMLSchema#string

Peter K Todd

http://www.w3.org/2001/XMLSchema#string

P2860

A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome

Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy

Molecular basis for impaired muscle differentiation in myotonic dystrophy

Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy

Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy

Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9

Six and Eya expression during human somitogenesis and MyoD gene family activation

Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population

RNA toxicity is a component of ataxin-3 degeneration in Drosophila

Genetic and chemical modifiers of a CUG toxicity model in Drosophila

P304

291-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2010.3

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20373340

http://www.w3.org/2001/XMLSchema#string

P932

2852186

http://www.w3.org/2001/XMLSchema#string